Defining Balanced Conditions for Inhibitor Screening Assays That Target Bisubstrate Enzymes

被引:48
作者
Yang, Jingsong [1 ]
Copeland, Robert A. [1 ]
Lai, Zhihong [1 ]
机构
[1] GlaxoSmithKline Inc, Dept Enzymol & Mechanist Pharmacol, Collegeville, PA 19426 USA
关键词
enzymatic assay; high-throughput screening; balanced conditions; bisubstrate; optimal screening conditions; IC(50); K(i); THROUGHPUT; DISCOVERY; DESIGN;
D O I
10.1177/1087057108328763
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High-throughput screening (HTS) is a common mechanism for identifying lead compounds for drug discovery efforts. Small molecules can inhibit enzymes by a variety of mechanisms, such as competitive, noncompetitive, and uncompetitive with respect to the substrate(s) of the catalytic reaction. To optimize the chances of finding the broadest diversity of inhibitor modalities during screening, one must run assays under "balanced" conditions where the potency of inhibitors with various modes of action falls within a similar range. When an enzyme reaction involves more than one substrate, the definition and assessment of the apparent potency of inhibitors (IC(50)), in relation to their true potency (K(i)), can be nontrivial. This article provides a theoretical analysis, on the basis of the Cheng-Prusoff derivation, of the IC(50)/K(i) relationship of bisubstrate enzyme reactions following various sequential kinetic mechanisms, as well as the application and limitations of this information for defining optimal screening conditions for such enzymes. (Journal of Biomolecular Screening 2009: 111-120)
引用
收藏
页码:111 / 120
页数:10
相关论文
共 14 条
[1]   Development of a mechanism-based assay for tissue transglutaminase - results of a high-throughput screen and discovery of inhibitors [J].
Case, A ;
Ni, J ;
Yeh, LA ;
Stein, RL .
ANALYTICAL BIOCHEMISTRY, 2005, 338 (02) :237-244
[2]   Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases [J].
Chene, Patrick .
DRUG DISCOVERY TODAY, 2008, 13 (11-12) :522-529
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   Mechanistic considerations in high-throughput screening [J].
Copeland, RA .
ANALYTICAL BIOCHEMISTRY, 2003, 320 (01) :1-12
[5]  
COPELAND RA, 2000, ENZYMES PRACTICAL IN
[6]  
COPELAND RA, 2005, EVALUATION ENZYME IN
[7]   Drug discovery: A historical perspective [J].
Drews, J .
SCIENCE, 2000, 287 (5460) :1960-1964
[8]   The druggable genome [J].
Hopkins, AL ;
Groom, CR .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :727-730
[9]   POINT OF CONVERGENCE OF SEQUENTIAL DOUBLE RECIPROCAL PLOTS AS A CRITERION OF BIREACTANT ENZYME KINETIC MECHANISMS - EVALUATION OF YEAST HEXOKINASE REACTION [J].
LUECK, JD ;
ELLISON, WR ;
FROMM, HJ .
FEBS LETTERS, 1973, 30 (03) :321-324
[10]  
Macarron Ricardo, 2002, Methods Mol Biol, V190, P1